Sattar, Naveed
Fitchett, David
Hantel, Stefan
George, Jyothis T.
Zinman, Bernard
Funding for this research was provided by:
The Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance
Article History
Received: 11 June 2018
Accepted: 4 July 2018
First Online: 31 July 2018
Duality of interest
: NS has consulted for Boehringer Ingelheim, Eli Lilly, Janssen and Novo Nordisk, and received grants support from Boehringer Ingelheim. DF has received honoraria from Sanofi, Merck & Co., Amgen, AstraZeneca, Eli Lilly and Boehringer Ingelheim. BZ has received research grants from Boehringer Ingelheim, AstraZeneca and Novo Nordisk, and honoraria from Janssen, Sanofi, Eli Lilly, Boehringer Ingelheim, Novo Nordisk and Merck. JTG and SH are employees of Boehringer Ingelheim.